TY - JOUR
T1 - Oxygen saturation targets for adults with acute hypoxemia in low and lower-middle income countries: a scoping review with analysis of contextual factors
AU - Herbst, Austin
AU - Goel, Swati
AU - Beane, Abi
AU - Brotherton, B. Jason
AU - Dula, Dingase
AU - Ely, E. Wesley
AU - Gordon, Stephen
AU - Haniffa, Rashan
AU - Hedt-Gauthier, Bethany
AU - Limbani, Felix
AU - Lipnick, Michael S.
AU - Lyon, Samuel
AU - Njoki, Carolyne
AU - Oduor, Peter
AU - Otieno, George
AU - Pisani, Luigi
AU - Rylance, Jamie
AU - Shrime, Mark G.
AU - Uwamahoro, Doris Lorette
AU - Vanderburg, Sky
AU - Waweru-Siika, Wangari
AU - Twagirumugabe, Theogene
AU - Riviello, Elisabeth
PY - 2023/4/17
Y1 - 2023/4/17
N2 - Knowing the target oxygen saturation (SpO2) range that results in the best outcomes for acutely hypoxemic adults is important for clinical care, training, and research in low-income and lower-middle income countries (collectively LMICs). The evidence we have for SpO2 targets emanates from high-income countries (HICs), and therefore may miss important contextual factors for LMIC settings. Furthermore, the evidence from HICs is mixed, amplifying the importance of specific circumstances. For this literature review and analysis, we considered SpO2 targets used in previous trials, international and national society guidelines, and direct trial evidence comparing outcomes using different SpO2 ranges (all from HICs). We also considered contextual factors, including emerging data on pulse oximetry performance in different skin pigmentation ranges, the risk of depleting oxygen resources in LMIC settings, the lack of access to arterial blood gases that necessitates consideration of the subpopulation of hypoxemic patients who are also hypercapnic, and the impact of altitude on median SpO2 values. This process of integrating prior study protocols, society guidelines, available evidence, and contextual factors is potentially useful for the development of other clinical guidelines for LMIC settings. We suggest that a goal SpO2 range of 90-94% is reasonable, using high-performing pulse oximeters. Answering context-specific research questions, such as an optimal SpO2 target range in LMIC contexts, is critical for advancing equity in clinical outcomes globally.
AB - Knowing the target oxygen saturation (SpO2) range that results in the best outcomes for acutely hypoxemic adults is important for clinical care, training, and research in low-income and lower-middle income countries (collectively LMICs). The evidence we have for SpO2 targets emanates from high-income countries (HICs), and therefore may miss important contextual factors for LMIC settings. Furthermore, the evidence from HICs is mixed, amplifying the importance of specific circumstances. For this literature review and analysis, we considered SpO2 targets used in previous trials, international and national society guidelines, and direct trial evidence comparing outcomes using different SpO2 ranges (all from HICs). We also considered contextual factors, including emerging data on pulse oximetry performance in different skin pigmentation ranges, the risk of depleting oxygen resources in LMIC settings, the lack of access to arterial blood gases that necessitates consideration of the subpopulation of hypoxemic patients who are also hypercapnic, and the impact of altitude on median SpO2 values. This process of integrating prior study protocols, society guidelines, available evidence, and contextual factors is potentially useful for the development of other clinical guidelines for LMIC settings. We suggest that a goal SpO2 range of 90-94% is reasonable, using high-performing pulse oximeters. Answering context-specific research questions, such as an optimal SpO2 target range in LMIC contexts, is critical for advancing equity in clinical outcomes globally.
KW - Africa
KW - context
KW - LMICs
KW - oxygen saturation targets
KW - SpO
U2 - 10.3389/fmed.2023.1148334
DO - 10.3389/fmed.2023.1148334
M3 - Short survey
SN - 2296-858X
VL - 10
SP - e1148334
JO - Frontiers in Medicine
JF - Frontiers in Medicine
M1 - 1148334
ER -